Eupraxia Pharmaceuticals Inc. Common Stock (EPRX)

Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $493M; returns 1 day -9.5%, 1 week +3.8%, 1 year +21.0%.

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX, TSX:EPRX) is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products using its proprietary Diffusphere™ technology.

Groups EPRX belongs to

• Clinical Stage Biotech
• Canada Companies
• Biotechnology
• Clinical Stage
• Biopharmaceutical
• Healthcare
• Long-Acting Injectables
• Unmet Medical Needs
• Life Sciences
• Gastroenterology

EPRX financial model: income statement, cash flow and balance sheet